Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

SparingVision clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our France, Ireland, Belgium and USA registers with SparingVision as lead sponsor. Synced 11 Nov 2026
4Current trials
2Recruiting now
0Drugs in these trials
4Trial registers
At a glance

SparingVision is the lead sponsor of 4 current clinical trials in our France, Ireland, Belgium and USA registers. 2 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Rod Cone Dystrophy.

ClinicalTrials.gov trials by status

  • Recruiting250%
  • Active, closed250%

Trials by phase

  • Not applicable250%
  • Phase 1/2250%
01

Clinical trials sponsored by SparingVision

4 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Natural History Study of Advanced RCD
NCT07854899 · Rod Cone Dystrophy
Not applicable Recruiting 2026-09 Ireland, France, Belgium
Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy
NCT07807111 · Retinitis Pigmentosa (RP), Rod Cone Dystrophy
Phase 1/2 Recruiting 2025-10 Ireland, France, Belgium
Promising ROd-cone DYstrophy Gene therapY
NCT05748873 · Retinitis Pigmentosa
Phase 1/2 Active, closed 2023-04 USA, France
Prospective Natural History Study of Retinitis Pigmentosa
NCT04285398 · Retinitis Pigmentosa
Not applicable Active, closed 2020-02 USA, France

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in SparingVision trials

3 conditions
Rod Cone Dystrophy2Retinitis Pigmentosa2Retinitis Pigmentosa (RP)1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in France42
Clinical trials in Ireland22
Clinical trials in Belgium22
Clinical trials in USA20

A trial with sites in more than one country appears in each of those registers.

04

Questions about SparingVision trials

How many clinical trials does SparingVision sponsor?

SparingVision is the lead sponsor of 4 current trials on ClinicalTrials.gov in our France, Ireland, Belgium and USA registers, as of the registry sync on 11 November 2026. Completed and withdrawn studies are not counted.

Are SparingVision trials recruiting?

Yes. 2 of its 4 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Does SparingVision have clinical trials in Ireland?

Yes. 2 trials in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 11 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.